Corporate Banner
Satellite Banner
Stem Cells, Cellular Therapy & Biobanking
>
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Access to Europe's only Laboratory Automation Event

Published: Thursday, April 21, 2011
Last Updated: Thursday, April 21, 2011
Bookmark and Share
Select Biosciences, organizers of European Lab Automation (ELA) 2011, are providing the opportunity to register free to visit the exhibition at ELA, Europe’s only event dedicated to laboratory automation.

Hamburg.gif

The European Lab Automation event will take place at the Congress Centre Hamburg (CCH), 30 June – 1 July in Hamburg, Germany. To gain access to this exhibition of leading laboratory automation innovations, simply register for a free exhibition only pass by visiting www.EuroLabAutomation.com.  

In addition to the exhibition, a busy schedule of ten conference streams will be available to full delegates only. To register as a full delegate and to gain access to the conference streams please visit www.EuroLabAutomation.com

To find out more about the events and services offered at ELA, please email s.marsden@selectbiosciences.com


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,400+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

European Life Science Awards Nominees Announced
The awards ceremony celebrates the very best of the industry’s achievements and precedes the Second European Lab Automation (ELA) conference and exhibition taking place from 30th- 31st May at the Congress Centre Hamburg.
Thursday, May 17, 2012
Biobanking Explored at ELA 2012
Select Biosciences, organisers of European Lab Automation (ELA), is pleased to announce that a conference stream dedicated to biobanking will return for a second year.
Wednesday, March 21, 2012
Bring a Buddy to ELA 2012
Select Biosciences, organisers of the Second European Lab Automation (ELA) at the Congress Center Hamburg, Germany from 30th-31st May 2012, is pleased to offer a ‘bring a buddy’ discount on conference registration fees.
Monday, February 13, 2012
ELA’s Life Science Awards Take Centre Stage for a Second Year
Select Biosciences announce that the second annual Life Science Awards ceremony will be held on the evening of 29th May at the Radisson Blu hotel, Hamburg, Germany.
Friday, January 13, 2012
Select Biosciences Gears Up for ELA 2012
Following the success of European Laboratory Automation (ELA) 2011, Select Biosciences has announced that it will be hosting next year’s conference and exhibition at the Congress Centre Hamburg (CCH), Germany, 30 - 31 May 2012.
Tuesday, November 08, 2011
New European Lab Automation Event Saw Outstanding Success
With 1523 attendees and 151 exhibitors and media partners, feedback from European Lab Automation was overwhelmingly positive.
Monday, August 01, 2011
Science and Innovation Celebrated at ELA with the Life Science Awards
Successful candidates were presented their awards by prestigious speakers and industry leaders at an evening ceremony, hosted by Select Biosciences and held at the Radisson Blu Hotel, Hamburg.
Wednesday, July 06, 2011
Bringing Automation into Biobanks
Select Biosciences, organizers of European Lab Automation (ELA) 2011, announces that the World Biobanking Summit will join the highly topical conference streams already confirmed at this unique laboratory automation conference and exhibition.
Friday, May 13, 2011
New Life Science Awards Event Precedes ELA 2011
Select Biosciences and co-organisers, Langton Howarth, announce that the inaugural Life Science Awards will be held on the evening of 29 June at the Radisson Blu Hotel, Hamburg, Germany.
Monday, April 11, 2011
Scientific News
Access Denied: Leukemia Thwarted by Cutting Off Link to Environmental Support
A new study reveals a protein’s critical – and previously unknown -- role in the development and progression of acute myeloid leukemia (AML), a fast-growing and extremely difficult-to-treat blood cancer.
New Weapon in the Fight Against Blood Cancer
This strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
Scientists Create CRISPR/Cas9 Knock-In Mutations in Human T Cells
In a project spearheaded by investigators at UC San Francisco, scientists have devised a new strategy to precisely modify human T cells using the genome-editing system known as CRISPR/Cas9.
Zebrafish Reveal Drugs that may Improve Bone Marrow Transplant
Compounds boost stem cell engraftment; could allow more matches for patients with cancer and blood diseases.
New Material Forges the Way for 'Stem Cell Factories'
Researchers have discovered the first fully synthetic substrate with potential to grow billions of stem cells. The researchcould forge the way for the creation of 'stem cell factories' - the mass production of human embryonic (pluripotent) stem cells.
Liver Regrown from Stem Cells
Scientists have repaired a damaged liver in a mouse by transplanting stem cells grown in the laboratory.
Immunotherapy Shows Promise for Myeloma
A strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
'Google Maps' for the Body
Scientists have revealed research that uses previously top-secret technology to zoom through the human body down to the level of a single cell that could be a game-changer for medicine.
Adaptimmune's Novel Cancer Therapeutics Show Positive Clinical Trial Results
The company has announced that positive data from its Phase I/II study of its affinity enhanced T-cell receptor (TCR) therapeutic targeting the NY-ESO-1 cancer antigen in patients with multiple myeloma has been published.
Stem Cells Rescue Patients from Mitochondrial Disease
A study led by OHSU researchers has revealed a critical first step in developing a new gene and stem cell regenerative technique for treating patients with mitochondrial disease.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!